Wednesday, December 13, 2017
News

Mylan launches hepatitis B pill in India

   SocialTwist Tell-a-Friend    Print this Page   COMMENT

New Delhi | Thursday, 2017 9:15:06 PM IST
 
Global drug firm Mylan on Thursday launched a tablet for the treatment of chronic hepatitis B among adults, the first in eight years to be approved for the management of chronic disease in India.

The tablets -- tenofovir alafenamide (TAF) -- was launched under the brand name "HepBest".

As compared to the earlier formulation of tenofovir (tenofovir disoproxil fumarate), TAF was found to have better efficacy with an enhanced renal as well as bone safety profile.

TAF also has greater plasma stability, which ensures efficient drug delivery to the site of action.

"India has an estimated 40 million HBV carriers, of which 15 per cent to 25 per cent could go on to suffer from cirrhosis and liver cancer," Rakesh Bamzai, President, India and Emerging Markets said, in a statement.

"By bringing the best-in-class drug for hepatitis B management to India, Mylan hopes to provide care for chronic hepatitis B patients and improve overall management of the disease."

Over two billion people worldwide are infected with the hepatitis B virus (HBV), of which more than 240 million have chronic liver infection, according to the World Health Organization (WHO).

These patients are at risk of developing serious illness and death, largely resulting from liver cirrhosis and liver cancer.

In 2014, Mylan had signed an agreement with Gilead to enhance access to TAF-based HIV treatments in developing countries.

As part of the licensing agreement, on US Food and Drug Administration (FDA) approval, Mylan received a technology transfer from Gilead, enabling it to manufacture low-cost versions of TAF, the statement said.

--IANS rt/him/vm

( 269 Words)

2017-12-07-20:44:08 (IANS)

Watch News Videos

 
  LATEST COMMENTS (0)
POST YOUR COMMENT
Comments Not Available
 
POST YOUR COMMENT
 
TRENDING TOPICS
 
 
 
CITY NEWS
MORE CITIES
 
MORE HEALTH NEWS
Try Indian spices to ward off winter sic...
Bangladesh moves to protect Rohingya chi...
Physical activity can improve survival i...
Decoded: What causes dementia...
Kidney disease may up risk of diabetes: ...
Twitter may help restore sense of well-b...
More...
 
INDIA WORLD ASIA
Journalist, author Rabisankar Bal dead...
Traditional knowledge diminishing among ...
CoA appreciates BCCI's decision to host ...
Has Rahul Gandhi started wearing Rudraks...
Father appeals to Sushma Swaraj to get d...
Ravi Shankar Prasad hits back at Rahul G...
More...    
 
 Top Stories
Roy Moore faces verdict of voters i... 
Terrorism charges filed against New... 
Playing Goddess on-screen challengi... 
US stocks tick up as Fed meeting be... 
Try Indian spices to ward off winte... 
New York bombing suspect warned Tru... 
Tejpal rape trial case : Bombay HC ... 
13-yr-old boy from TN drowns in Goa... 
 
 
loading...